Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
Enrico Matteini,1,* Laura Diluvio,1,* Sara Lambiase,1 Arnaldo Cioni,1 Ruslana Gaeta Shumak,1 Gaetana Costanza,2 Caterina Lanna,1 Giacomo Caldarola,3,4 Luca Bianchi,1 Elena Campione1 1Dermatology Unit, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, I...
Saved in:
Main Authors: | Matteini E (Author), Diluvio L (Author), Lambiase S (Author), Cioni A (Author), Gaeta Shumak R (Author), Costanza G (Author), Lanna C (Author), Caldarola G (Author), Bianchi L (Author), Campione E (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
by: Dillon KAL
Published: (2021) -
Insights, current status and future perspective of JAK inhibitors in the treatment of alopecia areata
by: Xingqi ZHANG
Published: (2022) -
Which is the ideal JAK inhibitor for alopecia areata - Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
by: Kabir Sardana, et al.
Published: (2023) -
A Real-Life Study on the Use of Tildrakizumab in Psoriatic Patients
by: Elena Campione, et al.
Published: (2023) -
Tratamento adjuvante com minoxidil oral para tratamento de alopecia areata refratária a inibidores de JAK
by: Carlos Gustavo Wambier, et al.
Published: (2020)